![ANA Therapeutics](https://storage.googleapis.com/dealroom-images-production/7f/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDIyLzA0LzEzL2YwMTQ3N2MzNjkxNjExMDc4MjI1NjViZjQyMDE0NWY5.png)
ANA Therapeutics
VerifiedFounded in response to the COVID-19 pandemic, we’re investigating niclosamide as a treatment for COVID-19.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$20—30m (Dealroom.co estimates Aug 2020.)
San Mateo California (HQ)
Authorizing premium user...